# Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer

> **NCT02079324** · PHASE1 · COMPLETED · sponsor: **Genexine, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** GX-051

## Key facts

- **NCT ID:** NCT02079324
- **Lead sponsor:** Genexine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02079324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02079324, "Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02079324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*